| Bombesin functionalized gold nanoparticles show in vitro and in vivo cancer receptor specificity N Chanda, V Kattumuri, R Shukla, A Zambre, K Katti, A Upendran, ... Proceedings of the National Academy of Sciences 107 (19), 8760-8765, 2010 | 392 | 2010 |
| Laminin receptor specific therapeutic gold nanoparticles (198AuNP-EGCg) show efficacy in treating prostate cancer R Shukla, N Chanda, A Zambre, A Upendran, K Katti, RR Kulkarni, ... Proceedings of the National Academy of Sciences 109 (31), 12426-12431, 2012 | 299 | 2012 |
| Radioactive gold nanoparticles in cancer therapy: therapeutic efficacy studies of GA-198AuNP nanoconstruct in prostate tumor-bearing mice N Chanda, P Kan, LD Watkinson, R Shukla, A Zambre, TL Carmack, ... Nanomedicine in Cancer, 753-774, 2017 | 295 | 2017 |
| [64Cu-NOTA-8-Aoc-BBN(7-14)NH2] targeting vector for positron-emission tomography imaging of gastrin-releasing peptide receptor-expressing tissues AF Prasanphanich, PK Nanda, TL Rold, L Ma, MR Lewis, JC Garrison, ... Proceedings of the National Academy of Sciences 104 (30), 12462-12467, 2007 | 264 | 2007 |
| Radiolabeled peptide conjugates for targeting of the bombesin receptor superfamily subtypes CJ Smith, WA Volkert, TJ Hoffman Nuclear medicine and biology 32 (7), 733-740, 2005 | 264 | 2005 |
| Novel series of 111In-labeled bombesin analogs as potential radiopharmaceuticals for specific targeting of gastrin-releasing peptide receptors expressed on human prostate … TJ Hoffman, H Gali, CJ Smith, GL Sieckman, DL Hayes, NK Owen, ... Journal of Nuclear Medicine 44 (5), 823-831, 2003 | 214 | 2003 |
| Gastrin releasing peptide (GRP) receptor targeted radiopharmaceuticals: a concise update CJ Smith, WA Volkert, TJ Hoffman Nuclear medicine and biology 30 (8), 861-868, 2003 | 190 | 2003 |
| Design and development of functionalized water-soluble phosphines: catalytic and biomedical implications KV Katti, H Gali, CJ Smith, DE Berning Accounts of chemical research 32 (1), 9-17, 1999 | 166 | 1999 |
| Radiochemical investigations of 177Lu-DOTA-8-Aoc-BBN [7-14] NH2: an in vitro/in vivo assessment of the targeting ability of this new radiopharmaceutical for PC-3 human prostate … CJ Smith, H Gali, GL Sieckman, DL Hayes, NK Owen, DG Mazuru, ... Nuclear medicine and biology 30 (2), 101-109, 2003 | 161 | 2003 |
| Radiochemical Investigations of 99mTc−N3S-X-BBN[7−14]NH2: An in Vitro/in Vivo Structure−Activity Relationship Study Where X = 0-, 3-, 5-, 8-, and 11-Carbon … CJ Smith, H Gali, GL Sieckman, C Higginbotham, WA Volkert, TJ Hoffman Bioconjugate chemistry 14 (1), 93-102, 2003 | 157 | 2003 |
| Radiochemical investigations of gastrin-releasing peptide receptor-specific [99mTc (X)(CO) 3-Dpr-Ser-Ser-Ser-Gln-Trp-Ala-Val-Gly-His-Leu-Met-(NH2)] in PC-3, tumor-bearing … CJ Smith, GL Sieckman, NK Owen, DL Hayes, DG Mazuru, R Kannan, ... Cancer research 63 (14), 4082-4088, 2003 | 144 | 2003 |
| Current and potential therapeutic uses of lanthanide radioisotopes CS Cutler, CJ Smith, GJ Ehrhardt, TT Tyler, SS Jurisson, E Deutsch Cancer biotherapy & radiopharmaceuticals 15 (6), 531-545, 2000 | 133 | 2000 |
| Nanocompatible chemistry toward fabrication of target-specific gold nanoparticles R Kannan, V Rahing, C Cutler, R Pandrapragada, KK Katti, V Kattumuri, ... Journal of the American Chemical Society 128 (35), 11342-11343, 2006 | 129 | 2006 |
| Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies BL Faintuch, R Teodoro, A Duatti, E Muramoto, S Faintuch, CJ Smith Nuclear medicine and biology 35 (4), 401-411, 2008 | 104 | 2008 |
| Pyrazolyl Derivatives as Bifunctional Chelators for Labeling Tumor-Seeking Peptides with the fac-[M(CO)3]+ Moiety (M = 99mTc, Re): Synthesis … S Alves, A Paulo, JDG Correia, L Gano, CJ Smith, TJ Hoffman, I Santos Bioconjugate chemistry 16 (2), 438-449, 2005 | 104 | 2005 |
| Optimization, biological evaluation and microPET imaging of copper-64-labeled bombesin agonists,[64Cu-NO2A-(X)-BBN (7–14) NH2], in a prostate tumor xenografted mouse model SR Lane, P Nanda, TL Rold, GL Sieckman, SD Figueroa, TJ Hoffman, ... Nuclear medicine and biology 37 (7), 751-761, 2010 | 102 | 2010 |
| Preparation of cyclotron-produced 186Re and comparison with reactor-produced 186Re and generator-produced 188Re for the labeling of bombesin ME Moustapha, GJ Ehrhardt, CJ Smith, LP Szajek, WC Eckelman, ... Nuclear medicine and biology 33 (1), 81-89, 2006 | 102 | 2006 |
| In Vitro and In Vivo Evaluation of a Novel 99mTc(CO)3-Pyrazolyl Conjugate of cyclo-(Arg-Gly-Asp-d-Tyr-Lys) S Alves, JDG Correia, L Gano, TL Rold, A Prasanphanich, R Haubner, ... Bioconjugate chemistry 18 (2), 530-537, 2007 | 98 | 2007 |
| Comparison of in vitro and in vivo properties of [99mTc] cRGD peptides labeled using different novel Tc-cores C Decristoforo, I Santos, HJ Pietzsch, JU Kuenstler, A Duatti, CJ Smith, ... QJ Nucl Med Mol Imaging 51 (1), 33-41, 2007 | 95 | 2007 |
| In vitro and in vivo analysis of [64Cu-NO2A-8-Aoc-BBN (7–14) NH2]: a site-directed radiopharmaceutical for positron-emission tomography imaging of T-47D human breast cancer tumors AF Prasanphanich, L Retzloff, SR Lane, PK Nanda, GL Sieckman, ... Nuclear medicine and biology 36 (2), 171-181, 2009 | 92 | 2009 |
